Kazuma Sasamura

Japanese Foundation For Cancer Research

Papers

1

Total Citations

6

H-Index

1

About

Kazuma Sasamura is a radiation oncology researcher whose work focuses on advancing ultrahypofractionated radiation therapy for prostate cancer, particularly through comparative treatment planning. His most cited study, published in 2023, systematically compares high-dose-rate brachytherapy (HDR-BT) against robotic and conventional stereotactic body radiotherapy (SBRT) for ultrahypofractionated prostate cancer treatment. This work provides critical dosimetric insights that help clinicians choose between these increasingly popular approaches, balancing tumor control with normal tissue sparing. With 6 citations already, this paper is gaining traction in the rapidly evolving field of prostate radiotherapy. Sasamura’s research directly addresses the clinical need for evidence-based comparisons between advanced radiation modalities, contributing to the optimization of treatment protocols. His work is particularly relevant as ultrahypofractionation becomes more widely adopted, offering patients shorter treatment courses without compromising outcomes. By clarifying the relative merits of HDR-BT and SBRT, Sasamura helps guide clinical decision-making in a landscape where technological options are expanding rapidly.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer
6 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Japanese Foundation For Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago